Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPz Cussons Regulatory News (PZC)

Share Price Information for Pz Cussons (PZC)

Share Price is delayed by 15 minutes
Get Live Data
87.40    2.10 (2.46%)
Bid:
87.00
Ask:
88.90
Spread: 1.90 (2.184%)
Market Cap: £367.39m
PZC Live PriceLast checked at - London Stock Exchange

Intraday Pz Cussons Share Chart

Trading Update

15 Dec 2016 07:00

RNS Number : 8800R
PZ CUSSONS PLC
15 December 2016
 

15 December 2016

 

PZ Cussons Plc

(the "Group")

 

Trading Update

 

PZ Cussons Plc announces its trading update in respect of the half year to 30 November 2016.

 

Overview

 

The board announces that the overall performance of the Group has been in line with expectations with profits broadly flat versus the comparative period.

 

The Group's balance sheet remains strong with cash generation for the period also in line with expectations.

 

First half trading

 

Europe

 

In the UK, performance in the washing and bathing division has been robust with new product launches under Imperial Leather, Carex and Original Source ensuring great shelf presence in a challenging trading environment.

 

In the beauty division, whilst a poor summer adversely affected sales of St Tropez in the UK, performance across the brand portfolio has been good for the remainder of the period, with new product launches in the second half of the year to include an extension of the Sanctuary range.

 

Performance in the smaller markets of Poland and Greece was in line with expectations.

 

Asia

 

In Australia, tough trading conditions have continued across all categories with higher levels of promotions required. Market shares have been maintained and new product launches are planned during the remainder of the year across both HPC and Food & Nutrition portfolios.

 

In Indonesia, good growth has continued across the brand portfolio. Additional brand investment has been incurred in the first half ahead of significant brand initiatives planned for the second half including a relaunch of the Cussons Kids range and a new range of Imperial Leather products.

 

Performance in the smaller markets of Thailand and the Middle East was in line with expectations.

 

Africa

 

In Nigeria, following the introduction of the new flexible exchange rate regime in June which led to a 40% devaluation of the naira, liquidity remains poor with the exchange rate continuing to weaken on both the interbank and secondary markets.

 

Market shares across personal care, home care, electricals and food and nutrition have either been held or grown in the period, although volumes in all categories are lower as a result of changes to relative pricing. The Group's diverse brand portfolio with product offerings at all price points is working well in an environment where the consumer is under significant inflationary pressure and down trading to lower price points and sizes.

 

Performance in the smaller markets of Ghana and Kenya has been in line with expectations.

 

Full year outlook

 

The strength of the Group's brand portfolio and innovation pipeline continues to ensure that the market shares of our products remain strong in all markets despite tough trading conditions.

 

Brand renovation and innovation will underpin the trading result in the second half in Europe and Asia, with various mitigating actions planned across the UK businesses to counter higher costs.

 

In Nigeria, the brand portfolio is well positioned for peak season in the country with the Group's heritage and experience serving it well through very challenging macro conditions.

 

The Group's balance sheet remains strong and well placed to pursue new opportunities as they arise.

 

Interim Announcement

 

Interim results for the half year to 30 November 2016 will be announced on Tuesday 24 January 2017.

 

- ENDS -

 

This announcement contains inside information.

 

 

For further information contact:

 

PZ Cussons Plc

Brandon Leigh - Chief Financial Officer

 

Tel: 0161 435 1236

Instinctif

Tim Linacre / Guy Scarborough

Tel: 020 7457 2020

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTGGGUWPUPQGQC
Date   Source Headline
29th Nov 202111:25 amRNSDirector/PDMR Shareholding
25th Nov 20214:40 pmRNSDirector/PDMR Shareholding
23rd Nov 20214:05 pmRNSAnnual General Meeting
9th Nov 20217:00 amRNSDirector/PDMR Shareholding
15th Oct 20217:00 amRNSPublication of Annual Report and notice of AGM
24th Sep 20219:00 amRNSDirector/PDMR Shareholding
22nd Sep 20217:00 amRNSTrading Statement
22nd Sep 20217:00 amRNSFinal Results
13th Sep 20213:00 pmRNSAppointment of Non Executive Director
27th Jul 202111:00 amRNSDirector/PDMR Shareholding
5th Jul 20214:00 pmRNSDirector/PDMR Shareholding
1st Jul 20217:00 amRNSTrading update
29th Jun 202110:45 amRNSNotice of pre-close trading update
25th Jun 20217:00 amRNSAppointment of Non Executive Director
27th Apr 20217:00 amRNSTrading Statement
25th Mar 20217:00 amRNSCapital Markets Day
22nd Mar 20211:00 pmRNSDirector/PDMR Shareholding
22nd Feb 20215:30 pmRNSDirector/PDMR Shareholding
3rd Feb 20219:00 amRNSDirector/PDMR Shareholding
26th Jan 20217:00 amRNSHalf-year Report
1st Dec 20203:45 pmRNSDirector/PDMR Shareholding
26th Nov 20202:30 pmRNSResult of AGM
26th Nov 20207:00 amRNSDirectorate Change
23rd Oct 202012:00 pmRNSPublication of Annual Report / Notice of AGM
20th Oct 20201:00 pmRNSHolding(s) in Company
1st Oct 20208:38 amRNSCompletion of Nutricima disposal
28th Sep 20203:00 pmRNSDirector/PDMR Shareholding
23rd Sep 20207:00 amRNSTrading Statement
23rd Sep 20207:00 amRNSBoard Change
23rd Sep 20207:00 amRNSFinal Results for the year ended 31 May 2020
14th Aug 20208:50 amRNSDirector Declaration
6th Jul 20209:05 amRNSDirector Declaration
30th Jun 20205:30 pmRNSDirector/PDMR Shareholding
19th Jun 20209:29 amRNSDirector/PDMR Shareholding
5th Jun 20202:15 pmRNSRevised reporting timetable
28th May 20201:01 pmRNSDirector/PDMR Shareholding
22nd May 202010:20 amRNSDirector Declaration
28th Apr 202011:33 amRNSDirector/PDMR Shareholding
16th Apr 20207:00 amRNSTrading Update for the Third Quarter 2020
14th Apr 20204:15 pmRNSBoard Change
2nd Apr 20207:00 amRNSUpdate on Settlement Agreement with Former CEO
19th Mar 20207:00 amRNSAppointment of new Chief Executive Officer
19th Mar 20207:00 amRNSBoard changes
18th Mar 20207:00 amRNSSale of Nutricima and completion of Luksja sale
20th Feb 20207:00 amRNSHolding(s) in Company
28th Jan 20207:00 amRNSHalf-year Report
12th Dec 20197:00 amRNSDirectorate Change
12th Dec 20197:00 amRNSTrading Update
30th Oct 20197:00 amRNSAppointment of Non-executive Directors
30th Sep 201911:15 amRNSCompletion of Minerva sale

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.